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Abstract
Background The purpose of this study was to investigate
the midterm clinical and radiographic outcomes of this new
treatment for Kienbo¨ck’s disease.
Methods We applied a new method involving drilling,
bone marrow transfusion, external fixation, and low-
intensity pulsed ultrasound for patients with Kienbo¨ck’s
disease. Between 2000 and 2006, the treatment was per-
formed in 18 patients (10 men and 8 women; 9 right wrists
and 9 left wrists). The preoperative Lichtman stages were
stage II in 4 cases, stage IIIa in 11 cases, and stage IIIb in 3
cases. The mean age at surgery was 44.9 years (range
16–68 years), and the mean follow-up period was
63 months (range 28–125 months). The overall results
were evaluated using the Mayo wrist score and Nakamura
scoring system for Kienbo¨ck’s disease. Magnetic reso-
nance imaging (MRI) was performed for all patients.
Results Wrist pain improved to no pain in 13 patients,
mild pain in 4 patients, and moderate pain in 1 patient. The
average wrist flexion–extension arc was 100 and averaged
120 % of the preoperative value. The average grip strength
increased from 50 to 85 % relative to the unaffected side.
On roentgenograms, the carpal height ratio (change from
0.53 to 0.51) and the Stahl index (change from 0.38 to
0.32) decreased slightly. On MRI, fatty marrow was
recovered in 11 patients (61 %) on proton density-weighted
images.
Conclusions This method can be used as a less-invasive
surgical treatment alternative for Kienbo¨ck’s disease. At an
average follow-up period of 6 years, this new treatment has
been shown to be a reliable and durable procedure for
patients with Lichtman stage II or stage III Kienbo¨ck’s
disease. Caution should be exercised for patients with a
fragmented lunate because of the risk of collapse and
nonunion of the lunate.
Introduction
Kienbo¨ck’s disease is a progressive wrist disorder charac-
terized by osteonecrosis of the lunate. The treatment of
Kienbo¨ck’s disease remains controversial, although
numerous surgical procedures have been described [1–10].
These surgical methods have some disadvantages, such as
large, invasive, and complicated procedures and uncertain
lunate bone regeneration. We considered that a less inva-
sive method would improve the clinical symptoms and lead
to regeneration of the lunate bone itself. We developed a
new treatment for Kienbo¨ck’s disease in 2000. At that time,
bone marrow (BM) transfusion had been applied for osteo-
synthesis, delayed union, and bone defects [11, 12]. Oste-
ogenic precursor cells, which are capable of producing
bone, have been demonstrated to be present among the
stromal and endothelial cells of the BM [13]. It has also
been shown that endothelial progenitor cells, CD34-posi-
tive cells, have vasculogenic properties and originate from
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the BM [14]. Low-intensity pulsed ultrasound (LIPUS) has
been adopted for delayed union since successful experi-
ments were first reported by Duarte [15]. In addition,
application of LIPUS has been shown to accelerate the
healing of fresh tibial fractures and distal radial fractures
[16, 17]. On the basis of these findings, we applied a new
method involving drilling, BM transfusion, external fixa-
tion (EF), and LIPUS to 4 patients with Lichtman stage II
or III Kienbo¨ck’s disease. We obtained good clinical
results with a three-year follow-up. To better understand
the treatment described in this study, we histopathologi-
cally examined the efficacies of drilling, BM transfusion,
and LIPUS for regeneration of necrotic bone in a rabbit
small-bone model. BM injection with drilling was effective
for revitalizing a severely necrotic small bone in the
experimental rabbit model [18]. Moreover, we verified that
LIPUS therapy accelerated bone regeneration in this model
[19]. The purpose of this study was to investigate the
midterm clinical and radiographic outcomes for a total of
18 patients with Kienbo¨ck’s disease treated by drilling, BM
transfusion, and LIPUS.
Materials and methods
Subjects
Between 2000 and 2006, the treatment was performed in 18
patients with Kienbo¨ck’s disease (10 men and 8 women; 9
right wrists and 9 left wrists) who visited the outpatient
department of our hospital. The research committee of the
hospital approved this human study. Nine dominant and 9
nondominant sides were affected. At the time of surgery, 3
patients were students and 15 patients were employed
(6 construction workers, 3 home workers, 3 agriculture
workers, 2 office workers, and 1 truck driver). The pre-
operative Lichtman stages were stage II in 4 patients, stage
IIIa in 11 patients, and stage IIIb in 3 patients. The ulnar
variance was neutral in 9 patients, positive in 4 patients,
and negative in 5 patients. The mean age at surgery was
44.9 years (range 16–68 years) and the mean follow-up
period was 63 months (range 28–125 months). Our indi-
cations for surgical intervention were diagnosis of Kie-
nbo¨ck’s disease at stages II, IIIa, and IIIb.
Surgical and treatment protocols
Under general anesthesia, we inserted two pins into the
second metacarpal and radial diaphysis to install a bridging
external fixator. We created a 2 cm transverse incision over
the lunate, retracted the extensor tendon with preservation
of the joint capsule, and placed a radiolucent drill guide
based on our profile over the joint capsule. Next, we drilled
three holes with a 2 mm diameter drill (Fig. 1a, b). We
collected BM samples (approximately 2 mL) from the
radius by aspiration using a 10 mL syringe with an
18-gauge needle (Fig. 1c). We transfused the BM into the
lunate through the drill holes to fill the space (approxi-
mately 2 mL; Fig. 2a, b). The external fixator (Stableloc;
Kobayashi Medical, Tokyo, Japan) was fixed in slight
traction with the wrist in a neutral position, and was
removed after 8 weeks (Fig. 3a, b). We applied traction to
the radiocarpal and intercarpal joints to create a 1 mm
opening to achieve distraction of the joints. The LIPUS
therapy was applied using a Sonic Accelerated Fracture
Healing System (SAFHS; Teijin Pharma, Tokyo, Japan).
The treatment head module delivered an ultrasound signal
Fig. 1 Surgical procedure. a Drilling of the lunate with our original
drill guide. b Radiograph obtained when the drill guide was set.
c Schema of bone marrow (BM) aspiration
Fig. 2 a We transfused the bone marrow (BM) into the lunate by
direct injection through the radiolucent drill guide based on our
profile over the joint capsule. b Schema of the BM transfusion
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composed of a burst width of 200 ls of 1.5 MHz sine
waves, with a repetition rate of 1 kHz and an average
spatiotemporal intensity of 30 mW/cm2. The head module
was placed dorsally relative to the wrist, and the skin was
protected using a standard ultrasound gel. LIPUS therapy
was introduced daily for 20 min, similar to its use to treat
bone nonunion or delayed union [15–17]. The period of
LIPUS ranged from 4 weeks, which allowed complete
wound healing, to 4 months, which allowed recovery of the
range of motion to some extent.
Assessment
Both preoperatively and postoperatively, all patients were
interviewed and examined for wrist pain, range of motion,
grip strength, and imaging studies by two of the authors
(T.O. and Y.H.) who did not perform any of the surgeries.
Pain was assessed using four grades [20]: no pain; occa-
sional mild pain that occurred when the wrist was exposed
to cold or increased workload; tolerable moderate pain that
occurred anytime at rest or at work; and severe to intol-
erable pain. The overall results were evaluated using the
Mayo wrist score [20] and the Nakamura scoring system
for Kienbo¨ck’s disease (Nakamura score) [3, 6]. At the
follow-up evaluation, a roentgenogram was obtained to
assess the carpal height ratio (CHR) and the Stahl index
(SI). Magnetic resonance imaging (MRI) was performed
for all patients within 1 month of surgery and annually
thereafter, using a 1.5 T system (Gyroscan NT Intera;
Philips Medical Systems, Best, The Netherlands). Coronal
two-dimensional proton density weighted (PDW) images
and fast field echo (FFE) images of the wrist were acquired
using a 47 mm microscopy surface coil (Philips Medical
Systems). The slice thickness was 1.5 mm and the slice
interval was 0.1 mm with a field of view of 50 mm. Under
these conditions, the lunate bones were imaged in eight
slices in the coronal view. In general, PDW images of
normal lunates exhibit high signal intensities, whereas FFE
images exhibit intermediate intensities. In comparison,
PDW images of the necrotic lunate demonstrate lower
signal intensities, while FFE images exhibit higher or lower
intensities [21]. We evaluated all eight slices. We consid-
ered that patients showed improvement on MRI when the
signals changed to nearly normal on at least four of the
eight slices.
Statistical analysis
We compared the clinical and radiographic results obtained
before and after surgery and analyzed the differences using
a paired t test. Differences were considered to be signifi-
cant when the p value was \0.05.
Results
Preoperative wrist pain was moderate in 15 patients and
severe in 3 patients. At the final follow-up, the wrist pain
had improved in all patients, specifically to no pain in 13
patients, mild pain in 4 patients, and moderate pain in 1
patient (Table 1).
The preoperative values of wrist extension and flexion
ranged from 20 to 70 (mean 43.0) and from 15 to 60
(mean 36.1), respectively. At the final follow-up, the mean
wrist extension angle was 53.3 (range 30–70) and the
mean wrist flexion angle was 49.1 (range 40–75). Com-
parisons of the preoperative and postoperative values in all
patients showed no significant postoperative improvements
in wrist extension (p = 0.99) and flexion (p = 0.99;
Table 1).
The preoperative mean grip strength was 77.9 % (range
45–130 %) relative to the unaffected side. At the final
follow-up, the mean grip strength was 102.5 % (range
75–135 %) relative to the unaffected side. Comparisons of
the preoperative and postoperative values in all patients
showed no significant postoperative improvements in grip
strength (p = 0.99; Table 1).
On radiographs, lunate collapse had progressed in most
cases. The CHR decreased significantly from 0.53 to 0.51
(p = 0.046). The SI decreased significantly from 0.38 to
0.32 (p = 0.001). In all cases of progressive collapse, these
radiographic changes occurred within one year after
removing the EF. On MRI, fatty marrow was recovered in
11 patients (61 %) on PDW images (Table 2). This
improvement on MRI emerged over the course of
1–2 years postoperatively.
Fig. 3 a Setting the EF in a neutral position with mild traction of the
wrist. b Schema of the EF setting and LIPUS stimulation
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At the final follow-up evaluation, the Mayo wrist score
was excellent in 8 patients, good in 4 patients, fair in 4
patients, and poor in 2 patients, while the Nakamura score
was excellent in 4 patients, good in 11 patients, fair in 3
patients, and poor in no patients (Tables 1, 2). The roent-
genogram and MRI findings of a representative case
(case 4) are shown in Fig. 4. The CHR changed from 0.50
to 0.51 and the SI changed from 0.41 to 0.40. The
lunate intensity on MRI showed improvement at 1.5 years
postoperatively, and this was maintained even at 10 years
postoperatively. The Nakamura score was good and the
Mayo wrist score was excellent.
Discussion
The following treatments for Kienbo¨ck’s disease have been
reported to have excellent outcomes: conservative therapy
[2], radial osteotomy [3, 6, 8], cancellous bone grafting
with EF [4], metaphyseal core decompression [5], vascu-
larized bone grafts [7], proximal row carpectomy [9], and
capitate shortening osteotomy [10]. However, the outcomes
of our method were never inferior to those of the above-
mentioned conventional treatments (Table 3). When com-
paring the different procedures, the most noticeable finding
in our clinical results was the improvement in grip strength.
With respect to pain, this improved with almost any
treatment. On the other hand, radiographs showed signifi-
cant lunate collapse. For radial shortening osteotomy, Koh
et al. [6] reported that the CHR changed from 0.52 to 0.51
and the SI changed from 0.31 to 0.28, while Watanabe
et al. [8] reported that the CHR changed from 0.52 to 0.51
and the SI changed from 0.43 to 0.40. Aspenberg et al. [22]
reported that the lunate harvested at one year after creation
in a monkey lunate malacia model was radiographically
flattened, although the joint cartilage was still normal in
this model. Most of the subchondral bone shell was
replaced with newly vascularized bone. They speculated
that revascularization was the probable cause of the col-
lapse. In our previously reported animal experiments, we
observed that BM-transfused necrotic bone maintained its
original shape for at least 8 weeks, although the original
shape was lost by 12 weeks [18]. It is likely that the
necrotic bone started to lose its integrity at 8 weeks during
the regenerative process, and this may have been the result
of high bone turnover, which was predominantly facilitated
by bone resorption. At 20 weeks, the collapsed bones in
our previous study were not soft and showed elasticity [18].
Considering these results, slight collapse of the lunate with
progression was inevitable for revitalization of the necrotic
Table 1 Summary of the clinical results
Case Sex Age at
operation
(years)
Follow-up
period
(months)
Wrist pain Grip strengtha ROM () wrist
extension
ROM () wrist flexion
Pre-op Post-op Pre-op Post-op Pre-op Post-op Pre-op Post-op
1 M 56 125 Moderate None 90 85 40 45 50 40
2 F 66 58 Moderate None 75 105 45 60 30 45
3 F 62 58 Moderate None 75 135 45 60 30 75
4 F 24 103 Severe None 130 125 70 65 60 60
5 M 68 84 Severe None 45 90 20 45 25 45
6 M 44 90 Moderate None 60 90 30 50 30 40
7 F 65 87 Moderate None 65 85 30 45 35 40
8 F 19 21 Moderate Mild 70 100 40 60 30 40
9 M 27 49 Severe None 60 110 45 60 15 50
10 F 50 84 Severe None 80 95 45 50 35 45
11 M 26 41 Moderate Mild 70 75 40 35 30 40
12 F 60 72 Severe Moderate 80 100 50 60 30 40
13 M 16 25 Moderate None 70 105 40 60 30 45
14 M 26 36 Severe Mild 80 90 30 30 50 60
15 M 41 68 Severe None 110 115 60 60 50 55
16 M 53 65 Moderate None 120 135 65 70 55 65
17 M 22 36 Moderate None 95 100 45 45 40 55
18 F 61 36 Moderate Mild 60 105 35 60 25 45
Mean ± SD 62.9 ± 28 77.9 ± 22 102.5 ± 16 43.0 ± 12 53.3 ± 10 36.1 ± 12 49.1 ± 10
p value 0.99 0.99 0.99
a The grip strength is given as the percentage of the strength on the unaffected side
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lunate. In our treatment, EF may reduce mechanical stress
on the lunate, and it was used in an attempt to maintain the
CHR and SI. In this study, we maintained traction for only
8 weeks to minimize the risk of infection or contracture.
However, extending the EF period to 12 weeks or more
might be beneficial.
Regarding the number of cells used for transfusion, there
is a report that healthy human adult BM osteoprogenitors
Table 2 Summary of the radiologic results
Case Lichtman’s stage CHR Stahl index Nakamura’s score Mayo wrist score MRI
Pre-op Post-op Pre-op Post-op Pre-op Post-op
1 IIIb IIIb 0.46 0.51 0.20 0.22 Good Good I
2 II IIIa 0.56 0.55 0.43 0.44 Excellent Good I
3 II IIIa 0.56 0.50 0.43 0.33 Good Excellent I
4 IIIa IIIa 0.50 0.51 0.41 0.40 Good Excellent I
5 IIIa IIIa 0.58 0.53 0.47 0.33 Good Fair U
6 IIIa IIIa 0.54 0.54 0.45 0.26 Excellent Excellent I
7 II IIIb 0.55 0.55 0.36 0.28 Good Excellent U
8 IIIa IIIb 0.45 0.47 0.35 0.27 Good Good I
9 IIIa IIIa 0.60 0.48 0.33 0.24 Good Fair U
10 IIIa IIIa 0.53 0.46 0.40 0.42 Good Excellent I
11 IIIa IIIa 0.59 0.48 0.40 0.45 Fair Poor U
12 IIIa IIIa 0.53 0.53 0.40 0.32 Fair Poor U
13 IIIa IIIa 0.49 0.47 0.37 0.33 Good Fair I
14 IIIb IIIb 0.48 0.46 0.31 0.28 Fair Fair U
15 II IIIa 0.57 0.60 0.47 0.42 Good Excellent I
16 IIIa IIIa 0.64 0.63 0.42 0.27 Excellent Excellent I
17 IIIa IIIa 0.51 0.56 0.33 0.26 Excellent Excellent I
18 IIIb IIIb 0.49 0.47 0.35 0.35 Good Good U
Mean (and SD) 0.53 ± 0.05 0.51 ± 0.04 0.38 ± 0.06 0.32 ± 0.07
p values 0.046 0.001
I improved, U unchanged
Fig. 4 Roentgenograms and MRI for case 4. The images show that
the lunate has not collapsed, and that the lunate intensity is recovered
on MRI. The upper panels show anteroposterior views on the
roentgenograms, the middle panels show lateral views on the
roentgenograms, and the lower panels show PDW images on MRI.
The preoperative images are shown on the left, together with the 1.5-,
2-, 3-, 7-, and 10-year postoperative images
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represent approximately 0.001–0.01 % of the nucleated
cells, according to a homogeneous population of human
mesenchymal cells isolated from BM taken from the iliac
crest [23]. However, there are no reports of the number of
mesenchymal stem cells in the BM of the radius, and we
were unable to determine the proportion of mesenchymal
stem cells in the radius. BM transplantation as a treatment
for osteonecrosis of the femoral head has been reported to
be more effective when a larger number of cells is trans-
planted [24]. On the other hand, Connolly [25] described
that concentrated BM is not always necessary for a small
bone, e.g., the carpal scaphoid. We also supposed that the
whole BM contained endothelial progenitor cells, platelets,
cytokines, and growth factors [26]. Asahara et al. [14]
reported that postnatal neovascularization does not rely
exclusively on sprouting from preexisting blood vessels
(angiogenesis); instead, endothelial progenitor cells circu-
late from the BM to become incorporated into and thus
contribute to postnatal physiological and pathological
neovascularization, which is consistent with postnatal
vasculogenesis. Based on these findings, the BM transfu-
sion that we performed is similar to the injection of
osteoprogenitor cells, and vasculogenesis can also be
expected. We are sure that direct transfusion of whole BM
makes sense. The effects of LIPUS for Kienbo¨ck’s disease
are unclear. In previous studies, LIPUS stimulation directly
affected osteogenic cells, leading to mineralized nodule
formation [27]. LIPUS therapy may provide an alternative
noninvasive method for osteoblast and tissue regeneration
to enhance osteogenesis. Takayama et al. [27] reported that
LIPUS stimulation did not affect the rate of cell prolifer-
ation but instead increased osteogenic differentiation. In
addition, LIPUS can improve the blood flow. Barzelai et al.
[28] reported the effects of LIPUS on tissue blood flow and
angiogenesis after limb ischemia in vivo. Rawool et al. [29]
described that power Doppler sonography revealed
increased vascularity around the fracture sites in LIPUS-
treated dogs. In our animal study [19], LIPUS alone and
LIPUS plus bone drilling were not effective for revitalizing
severely necrotic small tarsal bones in rabbits. However,
the combined method involving drilling, BM injection, and
LIPUS for small-bone necrosis significantly accelerated
new bone formation at 8 weeks [19]. Therefore, it is con-
sidered that LIPUS in conjunction with BM injection
synergistically promotes angiogenesis, vasculogenesis, and
bone formation. Kienbo¨ck’s disease is denoted an avascu-
lar necrosis because blood vessels are usually absent. In the
lunates in our other study, the trabecular bone structures
were segmented and fatty marrow was absent, which
potentially allows the formation of fibrous granulation
tissues, albeit in the presence of blood vessels [21].
Moreover, nutrient vessels enter the lunate in a distal-to-
proximal direction via the palmar and dorsal horns and
build an intraosseous vascular network [30]. If the pro-
genitor cells undergo repeated differentiation and prolif-
eration in the limited space of the lunate (which serves as a
scaffold), this can be expected to result in revitalization of
the necrotic lunate.
The present study has several limitations. First, the study
was retrospective and the number of cases was small. Sec-
ond, we could not determine the proportion of mesenchymal
stem cells in the transfused BM. Third, we have no evidence
for the appropriateness of the selected periods of LIPUS
(from 4 weeks to 4 months) and EF (8 weeks). Fourth, there
were no controls, and the relative contribution of each of
treatment modality (BM transplant, LIPUS, and EF) to the
overall results cannot be estimated. Finally, caution should
be exercised for patients with a fragmented lunate due to the
risk of collapse and nonunion of the lunate.
In summary, we applied a new method involving drilling,
BM transfusion, EF, and LIPUS to 18 patients with Lichtman
stage II or stage III Kienbo¨ck’s disease. At the final follow-
up, the wrist pain had improved in all patients, but the range
of motion and grip strength did not show any significant
postoperative improvements. On radiographs, lunate col-
lapse had progressed in most cases. On MRI, fatty marrow
was recovered in 11 patients (61 %). Nakamura’s total
assessment score was excellent in 4 patients, good in 11
patients, fair in 3 patients, and poor in no patients. At an
average follow-up period of six years, this method can be
used as a less-invasive surgical treatment, and has been
shown to be a reliable and durable procedure for patients with
Lichtman stage II or stage III Kienbo¨ck’s disease.
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